Home / Market News / $VALN

$VALN news and market catalysts

The 2 most recent market catalysts affecting $VALN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

2 catalysts 0 high impact 1 bullish 1 bearish Pharmaceuticals

Aug 14, 2026 Corporate Catalyst Bullish Impact 75

European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application

The EMA's validation of the Marketing Authorization Application for the Lyme disease vaccine candidate is a significant positive development for Valneva and Pfizer, as it moves the…

Aug 13, 2026 Corporate Catalyst Bearish Impact 55

Conference Call: Valneva Affirms FY2026 Sales Guidance of $169.795M-$187.360M vs $171.630M Est

Valneva's 8-K filing indicates that the company has reaffirmed its fiscal year 2026 sales guidance, keeping the range at $169.795 million to $187.360 million. This is a neutral eve…

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.